METiS TechBio Lists on Hong Kong Stock Exchange, Raising HKD 2.1 Billion

May 15, 2026
METiS TechBio has become the world's first publicly listed AI powered drug delivery company after debuting on the Hong Kong Stock Exchange, raising over HKD 2.1 billion in the largest healthcare IPO in Hong Kong so far in 2026.

METiS TechBio has become the world's first publicly listed AI powered drug delivery company after debuting on the Hong Kong Stock Exchange, announced in a press release. The company focuses on AI powered nanodelivery for large molecule biopharmaceuticals and raised more than HKD 2.1 billion through its global offering.

The listing, under stock code 7666.HK, marks the largest healthcare IPO fundraising in Hong Kong so far in 2026. The Hong Kong public offering was oversubscribed by over 6,900 times, locking up more than HKD 730 billion in subscription funds. The international placing received orders from more than 280 institutional investors and was oversubscribed 82 times.

The IPO was jointly sponsored by Jefferies, Deutsche Bank Securities Asia, and CITIC Securities Hong Kong. Eighteen cornerstone investors subscribed for a total of USD 148 million, with BlackRock leading the group with a USD 50 million allocation. Other participants included UBS Asset Management Singapore, Mirae Asset of South Korea, ORIX Corporation of Japan, and several Chinese public fund managers.

The company, founded six years ago, has become one of the fastest unicorns in China's AI pharmaceutical sector to reach an IPO milestone.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

AI Funding News AI Brief AI Brief (X)

More from: Funding

05/15
Blackstone Digital Infrastructure Trust Debuts on NYSE After $1.8 Billion IPO
05/15
Blaize Reports Q1 2026 Results and Launches AI Services Platform
05/15
BluSky AI Launches Regulation A Offering to Expand U.S. AI Infrastructure
05/15
Amp Raises $1.3 Billion to Build Shared AI Compute Grid
05/15
Iridium to Acquire Aireon and Expand Space-Based Aviation Capabilities

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like